MMP9 and ovarian carcinoma: These results indicate that Aur A or BRCA2 promotes or inhibits ovarian cancer cell invasion and migration possibly through reducing or inducing p53, E-cadherin, β-catenin expressions, and increasing or decreasing MMP2, MMP9, and MMP13 expressions.